Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:LAB CVE:MKT NASDAQ:PRE NYSE:SENS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLABStandard BioTools$1.23-1.6%$1.14$0.92▼$2.41$467.18M1.541.92 million shs1.49 million shsMKTDeepMarkitC$0.09-5.6%C$0.05C$0.04▼C$0.19C$1.05M0.2441,409 shs24,000 shsPREPrenetics Global$7.98-1.1%$8.15$3.09▼$11.99$96.54M0.1522,888 shs25,491 shsSENSSenseonics$0.58+3.0%$0.52$0.25▼$1.40$379.38M0.927.40 million shs11.83 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLABStandard BioTools0.00%-6.82%+12.84%+6.03%-46.98%MKTDeepMarkit0.00%0.00%+88.89%+41.67%-37.04%PREPrenetics Global0.00%+1.08%-13.88%+100.88%+37.74%SENSSenseonics0.00%+16.70%+14.74%-3.33%+23.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLABStandard BioTools3.8784 of 5 stars3.54.00.00.03.33.31.3MKTDeepMarkitN/AN/AN/AN/AN/AN/AN/AN/APREPrenetics Global1.8064 of 5 stars2.53.00.00.02.70.01.3SENSSenseonics2.3306 of 5 stars3.81.00.00.03.80.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLABStandard BioTools 3.00Buy$2.50103.25% UpsideMKTDeepMarkit 0.00N/AN/AN/APREPrenetics Global 3.00Buy$9.0012.85% UpsideSENSSenseonics 3.50Strong Buy$1.55167.29% UpsideCurrent Analyst Ratings BreakdownLatest MKT, LAB, PRE, and SENS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/17/2025LABStandard BioToolsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/17/2025SENSSenseonicsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy7/15/2025SENSSenseonicsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.257/8/2025SENSSenseonicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$1.10 ➝ $1.406/2/2025SENSSenseonicsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy$1.10(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLABStandard BioTools$174.43M2.68N/AN/A$1.27 per share0.97MKTDeepMarkit-C$102.00-10,291.67C$0.02 per share5.00C($0.03) per share-2.83PREPrenetics Global$41.52M2.34N/AN/A$14.04 per share0.57SENSSenseonics$23.68M16.02N/AN/A$0.07 per share8.28Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLABStandard BioTools-$138.88M-$0.35N/AN/AN/A-78.24%-22.44%-16.74%7/30/2025 (Estimated)MKTDeepMarkit-C$6.31M-C$0.06N/A∞N/AN/A-295.34%-190.23%N/APREPrenetics Global-$46.30M-$3.99N/AN/AN/A-115.91%-28.07%-22.27%10/6/2025 (Estimated)SENSSenseonics-$60.39M-$0.11N/AN/AN/A-362.30%-842.25%-67.99%N/ALatest MKT, LAB, PRE, and SENS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025LABStandard BioTools-$0.04N/AN/AN/A$39.83 millionN/A6/12/2025Q1 2025PREPrenetics GlobalN/A-$0.80N/A-$0.80N/A$17.31 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLABStandard BioToolsN/AN/AN/AN/AN/AMKTDeepMarkitN/A3.57%N/AN/AN/APREPrenetics Global$2.8035.11%N/AN/A N/ASENSSenseonicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLABStandard BioToolsN/A6.125.37MKTDeepMarkit0.820.354.68PREPrenetics GlobalN/A2.071.89SENSSenseonics59.172.472.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLABStandard BioTools53.74%MKTDeepMarkitN/APREPrenetics Global25.01%SENSSenseonics12.36%Insider OwnershipCompanyInsider OwnershipLABStandard BioTools23.16%MKTDeepMarkit8.42%PREPrenetics Global7.80%SENSSenseonics4.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableLABStandard BioTools620379.82 million291.86 millionOptionableMKTDeepMarkit6,40012.35 millionN/ANot OptionablePREPrenetics Global112.21 million11.25 millionNot OptionableSENSSenseonics90654.22 million573.90 millionN/AMKT, LAB, PRE, and SENS HeadlinesRecent News About These CompaniesSenseonics (NYSE:SENS) Upgraded to "Strong-Buy" at Lake Street CapitalJuly 19 at 6:39 AM | marketbeat.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call ...July 16, 2025 | gurufocus.comSenseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern TimeJuly 16, 2025 | globenewswire.comBrokers Set Expectations for Senseonics FY2027 EarningsJuly 16, 2025 | marketbeat.comSequel Med Tech expects full twiist launch in the fallJuly 15, 2025 | drugdeliverybusiness.comDSenseonics (NYSE:SENS) Now Covered by Analysts at TD CowenJuly 15, 2025 | marketbeat.comFY2028 EPS Estimates for Senseonics Boosted by HC WainwrightJuly 15, 2025 | marketbeat.comFY2026 EPS Estimates for Senseonics Boosted by HC WainwrightJuly 11, 2025 | americanbankingnews.comFY2026 EPS Estimates for Senseonics Raised by HC WainwrightJuly 10, 2025 | marketbeat.comNew glucose sensors, insulin patch pumps lead ADA’s Scientific SessionsJuly 3, 2025 | medtechdive.comMADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensorsJune 24, 2025 | medtechdive.comMSenseonics lays out hopes for next-gen CGM commercial timelinesJune 24, 2025 | drugdeliverybusiness.comDHere's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 WeeksJune 18, 2025 | zacks.comSenseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with DiabetesJune 4, 2025 | globenewswire.comSenseonics Holdings, Inc. Secures $57.5 Million in Public Offering and $20.3 Million from Private Placement with Abbott LaboratoriesMay 21, 2025 | quiverquant.comQSenseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private PlacementMay 21, 2025 | globenewswire.comRevisiting Senseonics After 4 Years: Still A Big Investment OpportunityMay 21, 2025 | seekingalpha.comSenseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics opens $50M public offering, $25M private placement with AbbottMay 15, 2025 | drugdeliverybusiness.comDSenseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private PlacementMay 15, 2025 | globenewswire.comSenseonics Holdings, Inc. (AMEX:SENS) Q1 2025 Earnings Call TranscriptMay 9, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback StocksWhich Analyst-Favorite Drone Stock Will Come Out on Top?By Nathan Reiff | June 25, 2025View Which Analyst-Favorite Drone Stock Will Come Out on Top?2 Under the Radar Space & Defense Stocks With Huge PotentialBy Leo Miller | July 1, 2025View 2 Under the Radar Space & Defense Stocks With Huge PotentialJoby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?By Jeffrey Neal Johnson | July 14, 2025View Joby vs. Archer: Which eVTOL Stock Is Better for Your Portfolio?Rocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseMKT, LAB, PRE, and SENS Company DescriptionsStandard BioTools NASDAQ:LAB$1.23 -0.02 (-1.60%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.23 0.00 (0.00%) As of 07/18/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.DeepMarkit CVE:MKTC$0.08 -0.01 (-5.56%) As of 07/18/2025 12:45 PM EasternDeepMarkit Corp. provides game-based marketing software services. The company operates DeepMarkit platform and MintCarbon.io platform, a web-based software-as-a-service platform that facilitates the minting of carbon credits into non-fungible tokens. The company was formerly known as Challenger Deep Resources Corp. and changed its name to DeepMarkit Corp. in October 2015. DeepMarkit Corp. was incorporated in 2007 and is headquartered in Calgary, Canada.Prenetics Global NASDAQ:PRE$7.98 -0.09 (-1.05%) Closing price 07/18/2025 03:58 PM EasternExtended Trading$7.98 0.00 (0.00%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.Senseonics NYSE:SENS$0.58 +0.02 (+2.98%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$0.58 0.00 (-0.16%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
